Comments
Loading...
Aurinia Pharmaceuticals Stock Guidance | NASDAQ:AUPH | Benzinga
Aurinia Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | AUPH | Aurinia Pharmaceuticals | FY | 2025 | — | — | — | $250.00M | $260.00M | $274.40M | Get Alert |
| 01/05/2024 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $176.00M | $176.00M | $174.71M | Get Alert |
| 01/05/2024 | AUPH | Aurinia Pharmaceuticals | Q4 | 2023 | — | — | — | $45.00M | $45.00M | $44.20M | Get Alert |
| 11/02/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $155.00M | $160.00M | $161.65M | Get Alert |
| 08/03/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $150.00M | $160.00M | $154.35M | Get Alert |
| 05/04/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $135.00M | $155.00M | $142.68M | Get Alert |
| 01/06/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2022 | — | — | — | $134.00M | $134.00M | $132.68M | Get Alert |
| 01/06/2023 | AUPH | Aurinia Pharmaceuticals | Q4 | 2022 | — | — | — | $28.40M | $28.40M | $26.97M | Get Alert |
FAQ
What is the most recent guidance for Aurinia Pharmaceuticals (AUPH)?
There have been no specific sales or earnings guidance reported for Aurinia Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.